Showing results (241-250 of 249) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
Chemosphere|February 25, 2025
Impact of manure and artificial fertilizer application on metal and metalloid distributions in agricultural soils and cropsM Felipe-Sotelo, M Brandtner, N I Ward, et al.The New England Journal of Medicine|September 8, 2001
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccineW E Barlow, R L Davis, J W Glasser, et al.Bioorganic & Medicinal Chemistry Letters|December 3, 2014
A reversed sulfonamide series of selective RORc inverse agonistsMonique B van Niel, Benjamin P Fauber, Matthew Cartwright, et al.Vaccine|September 15, 2004
Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean childrenJ S Kim, Y T Jang, J D Kim, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 2013
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1Christopher A Hurley, Wade S Blair, Richard J Bull, et al.Journal of Medicinal Chemistry|May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitorsJanusz J Kulagowski, Wade Blair, Richard J Bull, et al.Journal of Medicinal Chemistry|March 22, 2021
Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron MicroscopyJack A Terrett, Huifen Chen, Daniel G Shore, et al.Journal of Medicinal Chemistry|June 16, 2012
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2Mark Zak, Rohan Mendonca, Mercedesz Balazs, et al.Journal of Medicinal Chemistry|May 11, 2013
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2Mark Zak, Christopher A Hurley, Stuart I Ward, et al.Pageof 25